FREQUENT BOLUSING IS ASSOCIATED WITH BETTER GLYCEMIC OUTCOMES IN 7,494 YOUTH WITH TYPE 1 DIABETES USING THE OMNIPOD INSULIN MANAGEMENT SYSTEM

被引：0
|
作者：
Forlenza, G. [1 ]
Desalvo, D. [2 ]
Huyett, L. [3 ]
Jantz, J. [3 ]
Chang, A. [3 ]
Vienneau, T. [3 ]
Ly, T. [3 ]
机构：
[1] Univ Colorado, Barbara Davis Ctr Diabet, Aurora, CO USA
[2] Texas Childrens Hosp, Baylor Coll Med, Pediat Diabet & Endocrinol, Houston, TX 77030 USA
[3] Insulet Corp, Clin, Acton, MA USA
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2020年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
439
引用
收藏
页码：A170 / A171
页数：2
相关论文
共 50 条
  • [41] Activity Feature Attenuates Drop in Glucose for Individuals with Type 1 Diabetes Using Omnipod 5 Automated Insulin Delivery System
    Turner, Lauren V.
    Sherr, Jennifer L.
    Zaharieva, Dessi P.
    Baran, Jesica D.
    Bode, Bruce W.
    Brown, Sue A.
    Bzdick, Suzan
    Hansen, David W.
    Kingman, Ryan S.
    Laffel, Lori M.
    Shah, Viral N.
    Stone, Sheri L.
    Vienneau, Todd
    Huyett, Lauren M.
    Dumais, Bonnie
    Ly, Trang T.
    Riddell, Michael C.
    DIABETES, 2024, 73
  • [42] Glycemic Outcomes for Adult Type 1 Diabetes (T1D) with and without DKA Treated with an Electronic Glycemic Management System
    Messler, Jordan
    Vellanki, Priyathama
    Bode, Bruce W.
    Booth, Robert
    Clarke, John
    DIABETES, 2021, 70
  • [43] CLINIC-INTEGRATED BEHAVIORAL INTERVENTION FOR FAMILIES OF YOUTH WITH TYPE 1 DIABETES: EFFECTS ON GLYCEMIC AND FAMILY MANAGEMENT OUTCOMES
    Nansel, Tonja R.
    Iannotti, Ronald J.
    Liu, Aiyi
    ANNALS OF BEHAVIORAL MEDICINE, 2012, 43 : S81 - S81
  • [44] Glycaemic improvement in 3,436 people with type 1 diabetes using the Omnipod DASH® Insulin Management System over first 90 days of use
    Aleppo, G.
    DeSalvo, D. J.
    Lauand, F.
    Huyett, L. M.
    Chang, A.
    Vienneau, T.
    Ly, T. T.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 112 - 112
  • [45] Glycemic Outcomes with the Omnipod 5 Automated Insulin Delivery (AID) System Stratified by Baseline Hypoglycemia Risk among People with Type 1 Diabetes (T1D) Ages 2 to 70 Years
    Forlenza, Gregory P.
    Bode, Bruce W.
    Carlson, Anders L.
    Criego, Amy B.
    Brown, Sue A.
    Weinstock, Ruth S.
    Hansen, David W.
    Buckingham, Bruce A.
    Mehta, Sanjeev N.
    Laffel, Lori M.
    Sherr, Jennifer
    Levy, Carol J.
    Hirsch, Irl B.
    Macleish, Sarah A.
    Desalvo, Daniel
    Shah, Viral
    Bhargava, Anuj
    Jones, Thomas C.
    Aleppo, Grazia
    Huyett, Lauren M.
    Ly, Trang T.
    DIABETES, 2022, 71
  • [46] Impact of insulin pump therapy and blood β-OHB ketone monitoring on glycemic outcomes in youth with type 1 diabetes (T1D)
    Bismuth, Elise
    Svoren, Britta
    Volkening, Lisa
    Butler, Deborah
    Laffel, Lori
    DIABETES, 2007, 56 : A485 - A486
  • [47] WHICH CHARACTERISTICS ARE ASSOCIATED WITH ATTAINING AN OPTIMAL GLYCEMIC MANAGEMENT AMONG ADULTS LIVING WITH TYPE 1 DIABETES AND USING AUTOMATED INSULIN DELIVERY SYSTEMS?
    Wu, Z.
    Brazeau, A. -S.
    Messier, V.
    Lebbar, M.
    Courchesne, A.
    Rabasa-Lhoret, R.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A25 - A26
  • [48] Real-world glycaemic outcomes of >12,200 adults with type 1 diabetes using the Omnipod® 5 Automated Insulin Delivery (AID) system with cloud-based data management
    Wilmot, E. G.
    Lal, R. A.
    Aleppo, G.
    Huyett, L. M.
    Snow, K.
    Mendez, J. J.
    Hadjiyianni, I.
    Ly, T. T.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S119 - S120
  • [49] Long-Term Use of Omnipod® Insulin Management System Associated with Lower A1c in Adults with Established Diabetes and A1c=8%
    Tinsley, Liane J.
    Laffel, Lori M.
    Guo, Zijing
    Naik, Nisha
    Layne, Jennifer E.
    Ly, Trang T.
    Mehta, Sanjeev N.
    DIABETES, 2018, 67
  • [50] Patient-reported outcomes for 2,335 adults with type 2 diabetes using the Omnipod® Insulin Management System show glycaemic improvement over the first 90 days of use
    Huyett, L. M.
    Carlson, A.
    Jantz, J.
    Chang, A.
    Vienneau, T.
    Ly, T. T.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S343 - S344
12345